U.S. Markets closed

Takeda Pharmaceutical Company Limited (TKPYY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
26.295+0.645 (+2.515%)
At close: 3:59PM EDT
People also watch
Full screen
Previous Close25.650
Bid0.000 x
Ask0.000 x
Day's Range25.710 - 26.690
52 Week Range19.960 - 26.690
Avg. Volume42,760
Market Cap40.4B
PE Ratio (TTM)40.27
Earnings DateN/A
Dividend & Yield0.78 (3.06%)
Ex-Dividend Date2016-09-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • Seattle Genetics (SGEN) Q2 Loss Narrower than Expected
    Zacks22 hours ago

    Seattle Genetics (SGEN) Q2 Loss Narrower than Expected

    Seattle Genetics (SGEN) incurred narrower-than-expected loss in Q2 and provided an encouraging guidance for Adcetris.

  • American City Business Journals2 days ago

    Waltham's Tesaro grabs $100M in cancer drug partnership with Takeda

    Waltham-based Tesaro is capitalizing on the early success of its new cancer drug, handing over some development and commercial rights to Takeda in a deal worth up to $340 million plus royalties. Tesaro (TSRO) said Thursday that the once-daily pill, which is marketed in the U.S. as Zejula following an FDA approval in March, will be developed and sold by Takeda in Japan, where the drug giant is headquartered. Under the deal, Takeda will get development and commercial rights in four additional countries — South Korea, Taiwan, Russia and Australia — for all kinds of tumors except prostate cancer.

  • Reuters11 days ago

    Nikkei falls to more than 1-week lows as cyclical stocks weigh; Toshiba jumps

    Japan's Nikkei share average fell to a more than one-week low on Tuesday morning after cyclical stocks lost ground as a stronger yen hit sentiment, while Toshiba Corp rallied after news a U.S. hedge fund ...